Your browser doesn't support javascript.
loading
The uterine adenosarcoma with postoperative residual in a woman treated by total abdominal hysterectomy/bilateral salpingo-oophorectomy: A case report and review of literature.
Fadavi, Pedram; Garousi, Maryam; Soltani, Sepideh; Montazer, Fatemeh; Abolhasani, Maryam; Asgari, Salar; Mirzaee, Elahe.
Afiliação
  • Fadavi P; Department of Radiation Oncology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Garousi M; Department of Radiation Oncology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Soltani S; Department of Radiation Oncology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Montazer F; Department of Pathology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Abolhasani M; Oncopathology Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Asgari S; Department of Pathology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Mirzaee E; Department of Radiation Oncology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Cancer Rep (Hoboken) ; 6(10): e1891, 2023 10.
Article em En | MEDLINE | ID: mdl-37592402
ABSTRACT

BACKGROUND:

In patients with uterine adenosarcoma, a total abdominal hysterectomy (TAH) with bilateral salpingo-oophorectomy (BSO) is typically recommended as an initial treatment. There is no consensus on adjuvant therapies. CASE We report the case of a patient with uterine adenosarcoma with postoperative residual disease. We performed four courses of adjuvant chemotherapy, including Ifosfamide, Mesna, and Adriamycin, and whole pelvic radiation with a dose of 50.4 Gy/28 Fr.

CONCLUSION:

A combination of chemotherapy and radiotherapy may be a promising treatment option for uterine adenosarcoma with postoperative residual disease.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Adenossarcoma Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Adenossarcoma Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article